A. Sober

发表

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Martin F. Mihm, M. Ross, M. Atkins, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO.

Giovanni Parmigiani, Amanda Blackford, Hensin Tsao, 2010, Cancer research.

Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo.

M. Rajadhyaksha, R. Anderson, T. Flotte, 2001, Journal of the American Academy of Dermatology.

Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.

Donald R. Miller, G. Argenziano, S. Swetter, 2016, JAMA dermatology.

Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study.

M. Oliviero, M. Mihm, A. Kopf, 2001, Journal of the American Academy of Dermatology.

Final version of 2009 AJCC melanoma staging and classification.

Jeffrey E Gershenwald, Merrick I Ross, Charles M Balch, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognosis after initial recurrence of cutaneous melanoma.

A. Sober, A. Cosimi, J. Markowitz, 1991, Archives of surgery.

The burden of skin disease in the United States

D. Margolis, M. Weinstock, J. Resneck, 2017, Journal of the American Academy of Dermatology.

Management of cutaneous melanoma.

Michael B Atkins, Hensin Tsao, M. Atkins, 2004, The New England journal of medicine.

Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma

Gary S. Rogers, Natale Cascinelli, Lowell A. Goldsmith, 1992 .

Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic.

M. Mihm, A. Sober, R. Nazarian, 2012, Journal of the American Academy of Dermatology.

Malignant Melanoma: Prognostic Significance of “Microscopic Satellites” in the Reticular Dermis and Subcutaneous Fat

M. Mihm, A. Kopf, R. Friedman, 1981, Annals of surgery.

Early recognition of cutaneous melanoma.

M C Mihm, W. Clark, M. Mihm, 1979, JAMA.

Pregnancy and hormonal influences on malignant melanoma.

A. Sober, B. K. Schwartz, S. Zashin, 1987, The Journal of dermatologic surgery and oncology.

Clinical diagnosis of moles vs melanoma.

M. Weinstock, A. Sober, M. Goldstein, 1998, JAMA.

Clinical spectrum of cutaneous melanoma morphology

William M. Lin, A. Sober, H. Tsao, 2019, Journal of the American Academy of Dermatology.

Outcome of patients with de novo versus nevus-associated melanoma.

William M. Lin, A. Sober, A. Muzikansky, 2015, Journal of the American Academy of Dermatology.

Clinical Presentations of Melanoma

A. Marghoob, A. Halpern, M. Marchetti, 2018, Cutaneous Melanoma.

A clinical review of the evidence for the role of ultraviolet radiation in the etiology of cutaneous melanoma.

A. Sober, R. Langley, 1997, Cancer investigation.

The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.

A. Sober, H. Tsao, M. Hoang, 2014, Journal of the American Academy of Dermatology.

Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement.

M. Ross, C. Balch, D. Coit, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Current Concepts in Ultraviolet Carcinogenesis

A. Sober, R. Granstein, 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis.

M. Mihm, A. Sober, H. Byers, 1991, The American journal of pathology.

Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Donald R. Miller, C. Christiansen, A. Sober, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Method of Biopsy and Incidence of Positive Margins in Primary Melanoma

C. Balch, A. Sober, 2007, Annals of Surgical Oncology.

Biopsy of Suspected Melanoma

A. Sober, C. Bichakjian, T. Johnson, 2020, Cutaneous Melanoma.

Translating psoriasis guidelines into practice: Important gaps revealed.

A. Gottlieb, M. Lebwohl, R. Kirsner, 2016, Journal of the American Academy of Dermatology.

Long-term outcome of Spitz-type melanocytic tumors.

M. Mihm, A. Sepehr, T. Flotte, 2011, Archives of dermatology.

Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes.

A. Sober, A. Muzikansky, A. Cosimi, 2015, JAMA surgery.

Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma.

T. Louis, W. Willett, L. Kaplan, 1990, American journal of epidemiology.

Early detection of melanoma.

A. Sober, A J Sober, L S Albert, 1993, Cancer treatment and research.

Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.

A. Sober, A. Rhodes, L. S. Albert, 1990, Journal of the American Academy of Dermatology.

Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.

M. Mihm, T. Fitzpatrick, A. Sober, 1983, Journal of the American Academy of Dermatology.

Hats: design and protection from ultraviolet radiation.

A. Sober, M. Pathak, J. Keeling, 1989, Military medicine.

Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.

A. Sober, F. Haluska, C. Thiele, 1998, Cancer research.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma.

A. Sober, K. Niendorf, H. Tsao, 2004, The New England journal of medicine.

A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease

M. Mihm, A. Kopf, R. Lew, 1981, Annals of surgery.

Integrating Skin Cancer-Related Technologies into Clinical Practice.

D. Rigel, A. Sober, C. Cockerell, 2017, Dermatologic clinics.

Melanoma incidence trends.

A. Sober, C. Bevona, 2002, Dermatologic clinics.

A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma.

A. Sober, H. Tsao, K. Kwitkiwski, 2002, Journal of the American Academy of Dermatology.

Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.

V. Sondak, B. Storer, J. Gershenwald, 2016, Journal of the National Cancer Institute.

Increased thickness of pregnancy‐associated melanoma

M. Mihm, A. Sober, M. Berwick, 1995, The British journal of dermatology.

Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: absence of immunohistochemically detectable hormone receptors.

M. Mihm, A. Sober, F. Koerner, 1994, Human pathology.

Cutaneous melanoma in Japan and the United States: comparative prognostic factors.

A. Sober, 1989, The Journal of investigative dermatology.

Prognosis for polypoidal melanoma is determined by primary tumor thickness

M. Mihm, A. Sober, B. Bronstein, 1986, Cancer.

Prognostic Factors for Cutaneous Melanoma

A. Sober, 1984 .

Prognosis in malignant melanoma.

M. Mihm, T. Fitzpatrick, A. Sober, 1980, Journal of the American Academy of Dermatology.

On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanoma

M. Mihm, R. Lew, T. Fitzpatrick, 1979, Cancer.

Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.

M. Gadd, A. Sober, W. Souba, 2000, Archives of dermatology.

Association of nevus count with prevention attitudes and behaviors before melanoma diagnosis

Donald R. Miller, S. Swetter, A. Sober, 2016, Melanoma research.

The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999.

Donald R. Miller, M. Weinstock, A. Halpern, 2003, Journal of the American Academy of Dermatology.

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.

D. Finkelstein, A. Sober, F. Haluska, 2000, Archives of Dermatology.

Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8+ Immunity

G. Linette, F. Hodi, A. Sober, 2005, Clinical Cancer Research.

Surgical delay and mortality for primary cutaneous melanoma

S. Guhan, William M. Lin, G. Boland, 2020, Journal of American Academy of Dermatology.

Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature.

T. Fitzpatrick, A. Sober, H. Koh, 1984, JAMA.

Dermatologic manifestations of infection in the compromised host.

A. Sober, R. Rubin, J. S. Wolfson, 1983, Annual review of medicine.

Adjuvant therapy of melanoma with interferon‐alpha‐2b is associated with mania and bipolar syndromes

E. Jonasch, M. Gadd, A. Sober, 2000, Cancer.

Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma

T. Fitzpatrick, H. Nakagawa, A. Sober, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.

M. Mihm, T. Fitzpatrick, A. Sober, 1983, Journal of Investigative Dermatology.

Early death from clinical stage I melanoma.

M. Mihm, A. Kopf, R. Lew, 1983, The Journal of investigative dermatology.

Mucocutaneous Infections in the Immunocompromised Host

A. Sober, R. Johnson, 2002 .

Prognosis of clinical stage I melanoma patients with positive elective regional node dissection.

M. Mihm, A. Kopf, R. Lew, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy for melanoma.

T. Fitzpatrick, A. Sober, W. Wood, 1983, Surgery.

Genital lentiginosis: a clinical and histopathologic study.

A. Sober, R. Barnhill, A. Rhodes, 1990, Journal of the American Academy of Dermatology.

Martin C. Mihm, Jr and the history of the Pigmented Lesion Clinic at the Massachusetts General Hospital

A. Sober, H. Tsao, 2010, Journal of cutaneous pathology.

Food predictors of plasma beta-carotene and alpha-tocopherol: validation of a food frequency questionnaire.

W. Willett, B. Rosner, L. Kaplan, 1990, American journal of epidemiology.

Chemical and pharmacologic agents that cause hyperpigmentation or hypopigmentation of the skin.

A. Sober, E. Lerner, 1988, Dermatologic clinics.

Drug- and heavy metal--induced hyperpigmentation.

A. Sober, R. Granstein, 1981, Journal of the American Academy of Dermatology.

Dermatologic Manifestations of Infections in Immunocompromised Patients

A. Sober, R. Rubin, J. S. Wolfson, 1985, Medicine.

Discerning individuals at elevated risk for cutaneous melanoma.

A. Sober, R. Barnhill, S. Kang, 1992, Clinics in dermatology.

Possible association between malignant melanoma and breast cancer.

A. Sober, H. Koh, R. Carey, 1987, Archives of dermatology.

Therapy for cutaneous melanoma: an update.

A. Sober, V. Ho, 1990, Journal of the American Academy of Dermatology.

Continuing medical education (Therapy)

A. Sober, V. Ho, 1990 .

Cigarette smoking and malignant melanoma. Prognostic implications

R. Lew, T. Fitzpatrick, A. Sober, 1984, Cancer.

Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma.

G. Linette, M. Goldberg, F. Hodi, 2002, Archives of dermatology.

Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals.

M. Weinstock, M. Mihm, T. Fitzpatrick, 1989, JAMA.

MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability

K. Tsai, D. Bell, A. Sober, 2005, Journal of Medical Genetics.

The dysplastic nevus syndrome. A pedigree with primary malignant melanomas of the choroid and skin.

J. Weiter, A. Sober, D. Albert, 1985, Ophthalmology.

Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals.

M. Weinstock, M. Mihm, T. Fitzpatrick, 1987, JAMA.

Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.

M. Mihm, A. Sober, D. Ruiter, 1982, Journal of immunology.

Anorectal melanoma. A case report and brief review of the literature.

A. Sober, H. Hoover, W. Frank, 1992, The Journal of dermatologic surgery and oncology.

Diagnosis and management of nevi and cutaneous melanoma in infants and children.

M. Mihm, A. Sober, C. Fishman, 2002, Clinics in dermatology.

Connective tissue tumors in patients with cutaneous melanoma.

A. Sober, L. Marks, A. Rosenberg, 1994, Journal of the American Academy of Dermatology.

Solar exposure in the etiology of cutaneous melanoma.

A. Sober, 1987, Photo-dermatology.

Influence of estrogen administration on tumor characteristics and survival in women with cutaneous melanoma.

R. Lew, A. Sober, H. Koh, 1985, Journal of the National Cancer Institute.

Topical metronidazole therapy for rosacea.

A. Sober, P. Bleicher, J. H. Charles, 1987, Archives of dermatology.

Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group.

A. Sober, L. Drake, J. D. Fallon, 1994, Journal of the American Academy of Dermatology.

On naevi and melanomas in dysplastic naevus syndrome patients

A. Sober, W. Bergman, M. Crijns, 1993, Clinical and experimental dermatology.

Prevention of melanoma by recognition of its precursors.

T. Fitzpatrick, A. Sober, A. Rhodes, 1985, The New England journal of medicine.

Ultraviolet radiation and malignant melanoma.

A. Sober, H. Tsao, 1998, Clinics in dermatology.

Sunlight and skin cancer.

T. Fitzpatrick, A. Sober, 1985, The New England journal of medicine.

The surgical management of "in situ" melanoma.

A. Sober, H. Bogaars, J. Alper, 1982, The Journal of dermatologic surgery and oncology.

Outcome of patients with melanoma and histologically negative sentinel lymph nodes.

M. Mihm, M. Gadd, T. Flotte, 1999, Archives of surgery.

Periodic synopsis on pigmentation.

A. Sober, J. Nordlund, T. W. Hansen, 1985, Journal of the American Academy of Dermatology.

Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study.

M. Mihm, T. Fitzpatrick, H. Nakagawa, 1983, Journal of the American Academy of Dermatology.

Uveitis, poliosis, hypomelanosis, and alopecia in a patient with malignant melanoma.

A. Sober, H. Haynes, 1978, Archives of dermatology.

Melanoma risk in individuals with clinically atypical nevi.

M. Mihm, T. Fitzpatrick, A. Sober, 1994, Archives of dermatology.

Nevus of Ota with contralateral cerebral melanoma.

A. Sober, D. Albert, D. Sang, 1977, Archives of ophthalmology.

Adrenal activity during normal glucose tolerance.

A. Sober, H. Ruder, J. Sode, 1977, Acta endocrinologica.

Correlation Between the Evaluation of Pigmented Lesions by a Multi-spectral Digital Skin Lesion Analysis Device and the Clinical and Histological Features of Melanoma.

D. Rigel, L. Ferris, A. Sober, 2016, The Journal of clinical and aesthetic dermatology.

Results of WHO melanoma programme international study on computerized image analysis: 19

N. Cascinelli, A. Sober, R. MacKie, 1993 .

The malignant potential of small congenital nevocellular nevi. An estimate of association based on a histologic study of 234 primary cutaneous melanomas.

M. Mihm, T. Fitzpatrick, A. Sober, 1982, Journal of the American Academy of Dermatology.

Guidelines of care for the management of primary cutaneous melanoma.

A. Halpern, S. Swetter, D. Elder, 2019, Journal of the American Academy of Dermatology.

Sentinel lymph node biopsy and melanoma: 2010 update Part I.

A. Sober, L. Garibyan, William G. Stebbins, 2010, Journal of the American Academy of Dermatology.

An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.

M. Wick, T. Fitzpatrick, A. Sober, 1985, The Journal of investigative dermatology.

Sun exposure and skin disease.

A. Sober, C. Taylor, 1996, Annual review of medicine.

Precursors to skin cancer

A. Sober, A J Sober, J M Burstein, 1995, Cancer.

Ketoconazole therapy and exfoliative erythroderma.

A. Sober, P. Olmstead, R. Rand, 1983, Archives of Dermatology.

Year Book of Dermatology

T. Fitzpatrick, A. Sober, 1971, Journal of the Royal College of Physicians of London.

Primary cutaneous aspergillosis in a premature neonate

A. Sober, R. Granstein, L. First, 1980, The British journal of dermatology.

Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management.

M. Mihm, A. Sober, Z. Tannous, 2005, Journal of the American Academy of Dermatology.

Nonepidermal Origin of Malignant Melanoma Associated with a Giant Congenital Nevocellular Nevus

M. Mihm, A. Sober, W. Wood, 1981, Plastic and reconstructive surgery.

A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.

J. Shah, M. Mihm, C. Balch, 2011, Journal of the American Academy of Dermatology.

Continuin medical education Drug- and heavy metal-induced hyperpigmentation

A. Sober, R. Granstein, 1981 .

Does biopsy type influence survival in clinical stage I cutaneous melanoma?

A. Sober, J. Lederman, 1985, Journal of the American Academy of Dermatology.

Surgical management of primary cutaneous melanomas of the hands and feet.

M. Mihm, M. Gadd, A. Sober, 1997, Annals of surgery.

Ultra‐late recurrence (15 years or longer) of cutaneous melanoma

A. Sober, A. Cosimi, H. Tsao, 1997, Cancer.

Prolonged evolution of a lentigo maligna.

A. Sober, C. Bevona, V. Liu, 2004, Journal of the American Academy of Dermatology.

Lentigo maligna melanoma has no better prognosis than other types of melanoma.

M. S. Blois, W. Clark, M. Mihm, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rapid progression of lentigo maligna to deeply invasive lentigo maligna melanoma. Report of two cases.

T. Fitzpatrick, A. Sober, E. Michalik, 1983, Archives of dermatology.

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.

V. Sondak, B. Storer, J. Gershenwald, 2014, Journal of the American Academy of Dermatology.

Early detection of melanoma: reviewing the ABCDEs.

Jeremy S Bordeaux, Hensin Tsao, Susan C. Taylor, 2015, Journal of the American Academy of Dermatology.

Desmoplastic melanoma: clinicopathologic aspects of six cases.

M. Mihm, A. Sober, S. Salasche, 1992, Dermatology.

Guidelines of care for malignant melanoma

A. Sober, M. Turner, S. Salasche, 1993 .

Treatment of benign and atypical nevi with the normal-mode ruby laser and the Q-switched ruby laser: clinical improvement but failure to completely eliminate nevomelanocytes.

R. Anderson, A. Sober, J. Grevelink, 1999, Archives of dermatology.

Multiple cutaneous melanoma metastases of an extremity resembling Kaposi's sarcoma: use of regional perfusion.

A. Sober, B. Bronstein, H. Lancer, 1984, The Journal of dermatologic surgery and oncology.

Methotrexate-induced necrolysis.

A. Sober, K. M. Reed, 1983, Journal of the American Academy of Dermatology.

Diagnosis and management of skin cancer

A. Sober, A J Sober, 1983, Cancer.

Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis

M. Mihm, A. Kopf, D. Rigel, 1982 .

Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

M. Mihm, A. Kopf, D. Rigel, 1982, Annals of surgery.

The risk of progression of lentigo maligna to lentigo maligna melanoma

M. Weinstock, A. Sober, 1987, The British journal of dermatology.

Guidelines of care for primary cutaneous melanoma.

A. Halpern, J. Grichnik, A. Sober, 2001, Journal of the American Academy of Dermatology.

Local recurrence of generalized herpes zoster following x-irradiation.

K. Arndt, A. Sober, S. B. Guss, 1971, Archives of dermatology.

Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases.

A. Sober, H. Tsao, P. Lee, 1998, Journal of the American Academy of Dermatology.

Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.

A. Halpern, S. Swetter, J. Grichnik, 2011, Journal of the American Academy of Dermatology.

FROM THE ACADEMY Guidelines of care for the management of primary cutaneous melanoma

A. Halpern, S. Swetter, J. Grichnik, 2011 .

Melanoma treatment update.

A. Sober, H. Tsao, 2005, Dermatologic clinics.

Precursor lesions of melanoma: do they exist?

M. Mihm, A. Sober, R. Barnhill, 1992, Seminars in surgical oncology.

The spectrum of minimal deviation melanoma: a clinicopathologic study of 21 cases.

M. Mihm, A. Sober, R. Reed, 1986, Human pathology.

Primary melanoma of the skin: recognition and management.

M C Mihm, M. Mihm, T. Fitzpatrick, 1980, Journal of the American Academy of Dermatology.

IMMUNOLOGY AND CUTANEOUS MALIGNANT MELANOMA

A. Sober, 1976, International journal of dermatology.

Skin markings in the diagnosis and prognosis of cutaneous melanoma.

T. Fitzpatrick, A. Sober, T B Fitzpatrick, 1984, Archives of dermatology.

Desmoplastic neurotropic melanoma.

A. Sober, H. Tsao, R. Barnhill, 1997, Seminars in cutaneous medicine and surgery.

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

V. Sondak, M. Ross, B. Storer, 2010, Journal of the American Academy of Dermatology.

Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System

A. Sober, K. Harms, S. Wong, 2016, Annals of Surgical Oncology.

Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program.

Donald R. Miller, A. Halpern, B. Gilchrest, 2002, Cancer.

Detection of “thin” primary melanomas

A. Kopf, T. Fitzpatrick, A. Sober, 1983, CA: a cancer journal for clinicians.

Sentinel lymph node biopsy and melanoma: 2010 update Part II.

A. Sober, L. Garibyan, William G. Stebbins, 2010, Journal of the American Academy of Dermatology.

Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme.

D. Elder, M. Mihm, A. Cochran, 1991, Human pathology.

Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors.

M. Mihm, A. Sober, H. Tsao, 2013, Human pathology.

Diffuse melanosis secondary to metastatic malignant melanoma. Light and electron microscopic findings.

T. Fitzpatrick, A. Sober, G. Murphy, 1981, Journal of American Academy of Dermatology.

Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases

A. Sober, G. Dickersin, R. Barnhill, 1995, Cancer.

Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.

M. Mihm, T. Fitzpatrick, A. Sober, 1983, The Journal of investigative dermatology.

A new American Joint Committee on Cancer staging system for cutaneous melanoma

Martin F. Mihm, M. Ross, M. Atkins, 2000, Cancer.

Detection of microscopic melanoma metastases in sentinel lymph nodes

M. Mihm, M. Gadd, T. Flotte, 1999, Cancer.

Pregnancy and Dysplastic Nevus Syndrome-Reply

A. Sober, 1985 .

The changing mole.

A. Sober, 1985, JAMA.

Specializing in accountability: strategies to prepare a subspecialty workforce for care delivery redesign.

A. Kimball, A. Sober, V. Nambudiri, 2013, Academic medicine : journal of the Association of American Medical Colleges.

Prognostic factors for melanoma.

A. Sober, Arthur J Sober, Oliver J Wisco, 2012, Dermatologic clinics.

Polarized light photography in the evaluation of photoaging.

N Kollias, R. Anderson, N. Kollias, 1995, Journal of the American Academy of Dermatology.

Over-the-counter clobetasol propionate.

A. Sober, C. Otley, 1994, Archives of dermatology.

Levodopa therapy and malignant melanoma.

M. Wick, A. Sober, 1978, JAMA.

Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas.

R. Kenet, T. Fitzpatrick, A. Sober, 1993, Archives of dermatology.

Very late metastasis (27 years) of cutaneous malignant melanoma arising in a halo giant congenital nevus.

M. Mihm, A. Sober, R. Barnhill, 1994, Dermatology.

Leukoderma in association with giant congenital nevi: report of two cases.

A. Sober, R. Barnhill, V. A. Albert, 1992, Dermatology.

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

R. Lew, A. Sober, H. Koh, 1985, Medical and pediatric oncology.

Iritis in patients with cutaneous melanoma and vitiligo.

T. Fitzpatrick, A. Sober, D. Albert, 1978, Archives of ophthalmology.

Multiple agminated spindle cell nevi: unique clinical presentation and review.

A. Sober, J. Muhlbauer, H. Lancer, 1983, Journal of the American Academy of Dermatology.

Enhanced uptake of 3H-glucosamine by macrophages stimulated by macrophage-activating factor.

A. Sober, J. David, M. Haynie, 1979, Journal of immunology.

Patient preferences for adjuvant interferon alfa-2b treatment.

M. Atkins, J. Kirkwood, A. Sober, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.

K. Isselbacher, M. FitzGerald, D. Haber, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Novel Mutations in the p 16 / CDKN 2 A Binding Region of the Cyclin-dependent Kinase-4 Gene 1

A. Sober, F. Haluska, C. Thiele, 2022 .

Immunosuppression: a cause of porokeratosis?

A. Sober, G. Lederman, J. Lederman, 1985, Journal of the American Academy of Dermatology.

Clinical recognition of melanoma and its precursors.

A. Sober, R. Langley, 1998, Hematology/oncology clinics of North America.

Familial cutaneous melanoma

A. Sober, R. Barnhill, L. Lucchina, 1995, Melanoma research.

An Evidence‐based Staging System for Cutaneous Melanoma 1

Natale Cascinelli, Alan Houghton, Martin F. Mihm, 2004, CA: a cancer journal for clinicians.

Granulomatous eruption after BCG vaccine immunotherapy for malignant melanoma.

A. Sober, C. Shea, A. Cosimi, 1989, Journal of the American Academy of Dermatology.

Sentinel lymph node biopsy and melanoma: 2010 update

A. Sober, L. Garibyan, William G. Stebbins, 2010 .

The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels.

W. Willett, L. Kaplan, M. Stampfer, 1988, American journal of epidemiology.

Narrower margins for clinical stage I malignant melanoma.

M. Mihm, T. Fitzpatrick, A. Sober, 1982, The New England journal of medicine.

Melanoma in the young: Differences and similarities with adult melanoma

M. Mihm, A. Sober, F. Haluska, 2007, Cancer.

A History of Melanoma: From Hunter to Morton

J. Kirkwood, C. Balch, A. Sober, 2020, Cutaneous Melanoma.

Randomized trials and scientific methods.

A. Sober, D. Wrone, 1999, Archives of dermatology.

Conservative surgical management of superficially invasive cutaneous melanoma

M. Mihm, T. Fitzpatrick, A. Sober, 1984, Cancer.

Melanoma before and after Thomas B. Fitzpatrick.

M. Mihm, A. Sober, 2004, The Journal of investigative dermatology.

Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions

M. Mihm, A. Kopf, D. Rigel, 1982, Annals of surgery.

A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models.

M. Mihm, A. Kopf, D. Rigel, 1982, Annals of surgery.

The natural break points for primary-tumor thickness in clinical Stage I melanoma.

M. Mihm, A. Kopf, R. Lew, 1981, The New England journal of medicine.

A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease.

M. Mihm, A. Kopf, R. Lew, 1981, American journal of surgery.

A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.

M. Mihm, A. Kopf, R. Lew, 1981, Surgery.

Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes

M C Mihm, M. Mihm, A. Kopf, 1981, Cancer.

Biology of desmoplastic melanoma: a case-control comparison with other melanomas.

M. Mihm, T. Flotte, A. Sober, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Strategies for improving melanoma education and screening for men age ≥ 50 years

Donald R. Miller, A. Halpern, B. Gilchrest, 2002 .

A nonepidermal, primary malignant melanoma arising in a giant congenital melanocytic nevus 40 years after partial surgical removal.

M. Mihm, A. Sober, P. Lio, 2004, Journal of the American Academy of Dermatology.

DYSPLASTIC NEVI, CUTANEOUS MELANOMA, AND GYNECOLOGIC DISORDERS

A. Sober, R. Frisch, G. Wyshak, 1992, International journal of dermatology.

Erythema in the primary lesion of superficial spreading melanoma is not of prognostic importance

M. Mihm, R. Lew, T. Fitzpatrick, 1982, The British journal of dermatology.

The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death

Barbara L. Smith, M. Mihm, M. Silverstein, 2009, Cancer.

Melastatin expression and prognosis in cutaneous malignant melanoma.

A. Sober, J. McCarthy, J. Deeds, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histologic regression in malignant melanoma: an interobserver concordance study

M. Mihm, A. Sober, Sewon Kang, 1993, Journal of cutaneous pathology.

“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness

M. Mihm, A. Kopf, D. Rigel, 1984, Cancer.

Acquired Precursor Lesions and Phenotypic Markers of Increased Risk for Cutaneous Melanoma

A. Marghoob, A. Scope, A. Sober, 2018, Cutaneous Melanoma.

Prevalence of Melanoma Clinically Resembling Seborrheic Keratosis

M. Mihm, A. Sober, L. Izikson, 2016 .

Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases.

M. Mihm, A. Sober, L. Izikson, 2002, Archives of dermatology.

Cutaneous malignant melanoma: Prognostic guidelines for physicians and patients

M C Mihm, M. Mihm, A. Kopf, 1982, CA: a cancer journal for clinicians.

Lymphomatoid papulosis following Hodgkin's disease.

A. Sober, T. Harrist, G. Lederman, 1987, Journal of the American Academy of Dermatology.

A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.

A. Sober, H. Tsao, M. Bigby, 2001, Archives of dermatology.

Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival.

A. Sober, W. Goggins, H. Tsao, 2004, Archives of dermatology.

Multiple primary cutaneous melanomas

M. Mihm, A. Sober, Sewon Kang, 1992, Cancer.

Contrasting features of childhood and adolescent melanomas

A. Sober, H. Tsao, A. Friedmann, 2018, Pediatric dermatology.

Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute

F. Hodi, A. Sober, F. Haluska, 2005, Melanoma research.

Nonepidermal origin of cutaneous melanoma in a small congenital nevus.

A. Sober, S. Salasche, R. Barnhill, 1990, Archives of dermatology.

Childhood melanoma: a clinicopathological study of 22 cases

M. Mihm, A. Sober, D. Scalzo, 1997, Melanoma research.

Cutaneous malignant melanoma in the older patient.

A. Sober, B. T. Morris, 1986, Clinics in geriatric medicine.

Melastatin E xpression a nd P rognosis i n C utaneous Malignant M elanoma

A. Sober, J. McCarthy, J. Deeds, 2001 .

The Distribution of Microscopic Melanoma Metastases in Sentinel Lymph Nodes: Implications for Pathology Protocols

A. Sober, A. Muzikansky, A. Cosimi, 2012, The American journal of surgical pathology.

Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?

M. Mihm, M. Gadd, A. Sober, 2004, Archives of surgery.

Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death

Barbara L. Smith, M. Mihm, M. Silverstein, 2009, Cancer.

How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death

Barbara L. Smith, M. Mihm, M. Silverstein, 2009, Cancer.

The new melanoma staging system.

J. Gershenwald, C. Balch, S. Soong, 2001, Seminars in cutaneous medicine and surgery.

New TNM melanoma staging system: linking biology and natural history to clinical outcomes.

Martin F. Mihm, M. Ross, M. Atkins, 2003, Seminars in surgical oncology.

Melanoma fact sheet

A. Sober, Thomas B. Fitzpatrick, 1979, CA: a cancer journal for clinicians.

Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma

A. Sober, B. Seizinger, J. Vázquez, 1993, International journal of cancer.

Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis.

M. Mihm, A. Kopf, D. Rigel, 1983, Journal of the American Academy of Dermatology.

An estimate of the annual direct cost of treating cutaneous melanoma.

A. Sober, H. Tsao, G. Rogers, 1998, Journal of the American Academy of Dermatology.

Acute cholecystitis from metastatic melanoma to the gall–bladder in a patient with a low–risk melanoma

A. Sober, E. M. Bailey, R. Langley, 1997, The British journal of dermatology.

Skin lesions suspected to be melanoma should be photographed. Gross morphological features of primary melanoma associated with metastases.

M. Mihm, A. Kopf, R. Lew, 1982, JAMA.

Image analysis of Stage 1 melanoma (1.00–2.50 mm): lymphocytic infiltrates related to metastasis and survival

M. Mihm, A. Sober, R. Barnhill, 1992, Journal of cutaneous pathology.

A NEW MATHEMATICS, AND NEW COMPARATIVE EFFECTIVENESS CALCULATORS (CancerMath.net), FOR PREDICTING MELANOMA DEATH

Raymond A. Jean Ba, L. Leon Chen Bs, Sebastian Jara, 2009 .

Sunlight and dysplastic nevus risk. Results of a clinic‐based case‐control study

M. Weinstock, M. Stampfer, R. Lew, 1991, Cancer.

Cutaneous melanoma and bilateral retinoblastoma.

A. Sober, A. Rhodes, L. Albert, 1990, Journal of the American Academy of Dermatology.

The significance of augmented radiocolloid uptake by the spleen in patients with malignant melanoma.

R. Lew, A. Sober, K. Mckusick, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Unilateral segmental hyperhidrosis. Response to 20% aluminum chloride solution and plastic wrap.

A. Sober, A. Dworin, 1978, Archives of dermatology.

Sun exposure habits in patients with cutaneous melanoma: a case control study.

N. Cook, R. Lew, T. Fitzpatrick, 1983, The Journal of dermatologic surgery and oncology.

Contribution of health care factors to the burden of skin disease in the United States

D. Margolis, M. Weinstock, J. Resneck, 2017, Journal of the American Academy of Dermatology.

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy

Shannon C. Trotter, J. Stein, R. Dellavalle, 2017, Melanoma management.

Clinical characteristics of early cutaneous melanoma

M S Blois, M C Mihm, M. S. Blois, 1980, Cancer.

Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.

C. Balch, A. Sober, M. A. Nading, 2010, Seminars in cutaneous medicine and surgery.

Epidemiology of cutaneous melanoma. An update.

R. Lew, A. Sober, H. Koh, 1991, Dermatologic clinics.

Urgent access to a specialty care melanoma clinic is associated with a higher rate of melanoma detection.

A. Sober, A. Geller, H. Tsao, 2011, Journal of the American Academy of Dermatology.

Familial cutaneous melanoma and two‐mutational‐event modeling

D. Elder, A. Sober, D. Duke, 1993, Cancer.

A randomized trial to improve early detection and prevention practices among siblings of melanoma patients

K. Emmons, T. Heeren, B. Gilchrest, 2006, Cancer.

Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.

Maria L. Wei, Rajan P. Kulkarni, J. Stein, 2023, JAMA dermatology.

Skin cancer prevention and detection practices among siblings of patients with melanoma.

Donald R. Miller, K. Emmons, B. Gilchrest, 2003, Journal of the American Academy of Dermatology.

Metastasis of an Untreated Thin Melanoma in a Very Elderly Patient

A. Sober, M. Goihman‐Yahr, L. Albert, 1990, International journal of dermatology.

Effect of BANS location on the prognosis of clinical stage I melanoma: new data and meta‐analysis

M. Weinstock, T. Fitzpatrick, A. Sober, 1988, The British journal of dermatology.

The management of rosacea

A. Sober, 1970, Dermatology nursing.

Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death.

A. Kopf, R. Lew, T. Fitzpatrick, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Primary malignant melanoma of the external auditory canal: a case report with presentation as an aural polyp.

J. Nadol, A. Sober, R. Barnhill, 1992, The American journal of otology.

Basic skin cancer triage for teaching melanoma detection.

M A Weinstock, M. Weinstock, A. Sober, 1996, Journal of the American Academy of Dermatology.

Rabbit serum monoamine oxidase. II. Determinants of substrate specificity.

A. Sober, C. M. Mcewen, 1967, The Journal of biological chemistry.

Cutaneous Melanoma, 4th Edition

C. Balch, S. Soong, A. Houghton, 2005 .

Association between the anatomic distribution of melanoma and sex.

A. Troxel, A. Sober, M. Ming, 2007, Journal of the American Academy of Dermatology.

Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use.

W. Willett, M. Weinstock, M. Stampfer, 1992, The Journal of investigative dermatology.

Occurrence of melanoma in “dysplastic” nevus spilus: report of case and analysis by flow cytometry

M. Mihm, A. Sober, R. Barnhill, 1992, Journal of cutaneous pathology.

Evolution of a naevus spilus.

A. Sober, R. Barnhill, L. Falo, 1994, Dermatology.

Willingness-to-pay stated preferences for telemedicine versus in-person visits in patients with a history of psoriasis or melanoma.

A. Qureshi, J. Kvedar, E. Wittenberg, 2006, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: Survival analysis of 6,908 cases from the National Cancer Data Base.

V. Sondak, B. Storer, J. Gershenwald, 2014 .

Biopsy of Suspected Melanoma

A. Sober, C. Bichakjian, T. Johnson, 2018, Cutaneous Melanoma.

Rabbit serum monoamine oxidase. Purification and characterization.

A. Sober, C. M. Mcewen, K. Cullen, 1966, The Journal of biological chemistry.

Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period.

M C Mihm, M. Mihm, A. Sober, 1990, Archives of dermatology.

Computerized Digital Image Analysis: An Aid for Melanoma Diagnosis

A. Sober, A J Sober, J M Burstein, 1994, The Journal of dermatology.

Epidemiology of cutaneous melanoma.

R. Lew, A. Sober, H. Koh, 1985, Dermatologic clinics.

Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma.

G. Linette, M. Mihm, M. Gadd, 2000, Cancer journal.

Does wide excision as the initial diagnostic procedure improve prognosis in patients with cutaneous melanoma?

A. Sober, J. Lederman, 1986, The Journal of dermatologic surgery and oncology.

Association between endometriosis, dysplastic naevi and history of melanoma in women of reproductive age.

A. Sober, R. Frisch, G. Wyshak, 1997, Human reproduction.

Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.

M. Mihm, A. Kopf, R. Lew, 1983, The Journal of investigative dermatology.

Acral lentiginous melanoma (including in situ melanoma) arising in association with naevocellular naevi

M. Mihm, A. Sober, M. Kawashima, 1996, Melanoma research.

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Diagnosis and management of malignant melanoma.

M. Mihm, T. Fitzpatrick, A. Sober, 1986, Comprehensive therapy.

Cutaneous melanoma: Opportunity for cure

A. Sober, 1991, Ca.

Improvements in the Staging of Cutaneous Squamous-Cell Carcinoma in the 7th Edition of the AJCC Cancer Staging Manual

A. Sober, N. Liégeois, W. Sharfman, 2010, Annals of Surgical Oncology.

A risk adjustment approach to estimating the burden of skin disease in the United States

D. Margolis, M. Weinstock, J. Resneck, 2018, Journal of the American Academy of Dermatology.

Relationships between primary tumor size , number of involved nodes and survival among 8 , 044 cases of Merkel cell carcinoma

V. Sondak, A. Sober, D. Byrd, 2019 .

Levodopa and Melanoma-Reply

M. Wick, A. Sober, 1979 .

Increased thickness of pregnancy‐associated melanoma: a study of the MGH pigmented lesion clinic 155

M. Mihm, A. Sober, R. Barnhill, 1993 .

Association of nevus count with prevention attitudes and behaviors before melanoma diagnosis

Donald R. Miller, S. Swetter, A. Sober, 2016, Melanoma research.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Digital epiluminescence microscopy in the evaluation of pigmented lesions: a brief review.

A. Sober, 1993, Seminars in surgical oncology.

Sentinel lymph node biopsy and melanoma: 2010 update Part I.

A. Sober, L. Garibyan, William G. Stebbins, 2010, Journal of the American Academy of Dermatology.

Cutaneous Carcinogenic Effects of Sunlight in Humans

R. Lew, T. Fitzpatrick, A. Sober, 1977 .

A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.

J. Shah, M. Mihm, C. Balch, 2011, Journal of the American Academy of Dermatology.

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

M. Mihm, G. Dranoff, A. Sober, 1997, Human gene therapy.

Congenital melanocytic nevi and DNA content. An analysis by flow and image cytometry

A. Sober, Sewon Kang, Cynthia Cohen, 1994, Cancer.

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

V. Sondak, M. Ross, B. Storer, 2010, Journal of the American Academy of Dermatology.

Progress in Clinical and Biological Research, Volume 256: Advances in Pigment Cell Research

A. Sober, V. Ho, 1990 .